The FY26 ALS Research Program Therapeutic Idea Award supports new, innovative, high-risk, high-gain ideas focused on ALS drug or therapy discovery. It funds hypothesis-driven studies expected to generate preliminary data for future therapeutic avenues. Applications may succeed without preliminary data, emphasizing the strength of the approach and potential impact.
Open to any type of entity without restrictions, subject to additional clarifications in eligibility text.
